Liabilities and Equity in USD of GROOVE BOTANICALS INC. from Q1 2011 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
GROOVE BOTANICALS INC. quarterly Liabilities and Equity history and change rate from Q1 2011 to Q3 2025.
  • GROOVE BOTANICALS INC. Liabilities and Equity for the quarter ending 30 Sep 2025 was $8,164, a 27% decline year-over-year.
Source SEC data
View on sec.gov
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Change (%)

GROOVE BOTANICALS INC. Quarterly Liabilities and Equity (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $8,164 -$2,961 -27% 30 Sep 2025 10-Q 19 Nov 2025 2026 Q2
Q2 2025 $3,686* -$3,050,314 30 Jun 2025 10-Q 19 Aug 2025 2026 Q1
Q1 2025 $4,520* -$2,137,480 31 Mar 2025 10-Q 19 Nov 2025 2026 Q2
Q4 2024 $4,733* -$2,500,267 31 Dec 2024 10-Q 25 Feb 2025 2025 Q3
Q3 2024 $11,125 +$7,902 30 Sep 2024 10-Q 14 Nov 2024 2025 Q2
Q2 2024 $3,054,000 30 Jun 2024 10-Q 22 Aug 2024 2024 Q1
Q1 2024 $2,142,000 +$2,136,952 31 Mar 2024 10-K/A 25 Aug 2025 2025 FY
Q4 2023 $2,505,000 31 Dec 2023 10-Q 14 Feb 2024 2023 Q3
Q3 2023 $3,223* 30 Sep 2023 10-Q 11 Jan 2024 2023 Q2
Q1 2023 $5,048* 31 Mar 2023 10-K 15 Aug 2024 2024 FY
Q4 2017 $295,817 -$76,025 -20% 31 Dec 2017 10-Q 25 Apr 2019 2018 Q3
Q3 2017 $298,421 -$60,511 -17% 30 Sep 2017 10-Q 25 Apr 2019 2018 Q2
Q2 2017 $302,533 -$63,200 -17% 30 Jun 2017 10-Q 25 Apr 2019 2018 Q1
Q1 2017 $325,220 -$48,408 -13% 31 Mar 2017 10-Q 25 Apr 2019 2018 Q3
Q4 2016 $371,842 -$2,340,867 -86% 31 Dec 2016 10-Q 11 Jan 2019 2017 Q3
Q3 2016 $358,932 -$2,373,104 -87% 30 Sep 2016 10-Q 11 Jan 2019 2017 Q2
Q2 2016 $365,733 -$2,345,903 -87% 30 Jun 2016 10-Q 11 Jan 2019 2017 Q1
Q1 2016 $373,628 -$2,373,629 -86% 31 Mar 2016 10-K 11 Jan 2019 2017 FY
Q4 2015 $2,712,709 -$65,986 -2.4% 31 Dec 2015 10-Q 23 Feb 2016 2015 Q3
Q3 2015 $2,732,036 -$19,711 -0.72% 30 Sep 2015 10-Q 23 Nov 2015 2015 Q2
Q2 2015 $2,711,636 +$89,982 +3.4% 30 Jun 2015 10-Q 10 Sep 2015 2015 Q1
Q1 2015 $2,747,257 +$16,014 +0.59% 31 Mar 2015 10-K 28 Aug 2018 2016 FY
Q4 2014 $2,778,695 +$187,422 +7.2% 31 Dec 2014 10-Q 02 Jul 2015 2014 Q3
Q3 2014 $2,751,747 +$137,626 +5.3% 30 Sep 2014 10-Q 18 May 2015 2014 Q2
Q2 2014 $2,621,654 -$147,850 -5.3% 30 Jun 2014 10-Q 04 Nov 2014 2014 Q1
Q1 2014 $2,731,243 +$165,222 +6.4% 31 Mar 2014 10-K 14 Aug 2015 2014 FY
Q4 2013 $2,591,273 +$34,604 +1.4% 31 Dec 2013 10-Q/A 07 Apr 2014 2013 Q3
Q3 2013 $2,614,121 +$61,157 +2.4% 30 Sep 2013 10-Q 19 Nov 2013 2013 Q2
Q2 2013 $2,769,504 +$193,958 +7.5% 30 Jun 2013 10-Q/A 12 Sep 2013 2013 Q1
Q1 2013 $2,566,021 -$49,239 -1.9% 31 Mar 2013 10-K 30 Sep 2014 2013 FY
Q4 2012 $2,556,669 -$59,677 -2.3% 31 Dec 2012 10-Q 21 Mar 2013 2012 Q3
Q3 2012 $2,552,964 -$100,101 -3.8% 30 Sep 2012 10-Q 17 Dec 2012 2012 Q2
Q2 2012 $2,575,546 -$116,926 -4.3% 30 Jun 2012 10-Q/A 20 Aug 2012 2012 Q1
Q1 2012 $2,615,260 -$85,372 -3.2% 31 Mar 2012 10-K 20 Aug 2013 2012 FY
Q4 2011 $2,616,346 31 Dec 2011 10-Q 14 Feb 2012 2011 Q3
Q3 2011 $2,653,065 30 Sep 2011 10-Q 15 Nov 2011 2011 Q2
Q2 2011 $2,692,472 30 Jun 2011 10-Q 15 Aug 2011 2011 Q1
Q1 2011 $2,700,632 31 Mar 2011 10-K 13 Jul 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.